This inventor holds 3 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1985-1986.
Company Filing History:
Years Active: 1985-1986
Title: The Innovations of Harald Ritzel
Introduction
Harald Ritzel is a notable inventor based in Mainz, Germany. He has made significant contributions to the field of biochemistry, particularly in the development of novel compounds with therapeutic applications. With a total of 3 patents, his work has garnered attention in both academic and industrial circles.
Latest Patents
Ritzel's latest patents include groundbreaking research on novel polypeptides that exhibit an .alpha.-amylase-inhibiting action. This research outlines a process for creating cyclic polypeptides, which have potential applications in managing diabetes. Additionally, he has developed antidiabetic salicylic acid derivatives, which are designed to serve as effective pharmaceutical formulations for treating diabetes.
Career Highlights
Throughout his career, Harald Ritzel has been associated with Hoechst Aktiengesellschaft, a prominent company in the pharmaceutical industry. His work has not only advanced scientific understanding but has also contributed to the development of new therapeutic agents.
Collaborations
Ritzel has collaborated with several esteemed colleagues, including Volker Hitzel and Rudi Weyer. These partnerships have facilitated the exchange of ideas and have led to innovative solutions in their respective fields.
Conclusion
Harald Ritzel's contributions to the field of biochemistry and his innovative patents highlight his role as a significant inventor. His work continues to influence the development of new treatments for diabetes and other health conditions.